Anna Skowronska

Birmingham, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 14 publications

ACKR1/Duffy-null genotype testing for clozapine: A guideline developed by the UK Centre of Excellence in Regulatory Science and Innovation in Pharmacogenomics (CERSI-PGx).

ACKR1/Duffy-null genotype testing for clozapine: A guideline developed by the UK Centre of Excellence in Regulatory Science and Innovation in Pharmacogenomics (CERSI-PGx).

Journal: British journal of clinical pharmacology

Published: March 31, 2026

Effect of CYP1A2, CYP2D6, and CYP3A4 Variation on Antipsychotic Treatment Outcomes.

Effect of CYP1A2, CYP2D6, and CYP3A4 Variation on Antipsychotic Treatment Outcomes.

Journal: Pharmaceuticals (Basel, Switzerland)

Published: May 06, 2025

Identification of novel 3D-genome altering and complex structural variants underlying retinitis pigmentosa type 17 through a multistep and high-throughput approach.

Identification of novel 3D-genome altering and complex structural variants underlying retinitis pigmentosa type 17 through a multistep and high-throughput approach.

Journal: Frontiers in genetics

Published: July 24, 2024

The Impact of Diabetes and Glucose-Lowering Therapies on Hepatocellular Carcinoma Incidence and Overall Survival.

The Impact of Diabetes and Glucose-Lowering Therapies on Hepatocellular Carcinoma Incidence and Overall Survival.

Journal: Clinical therapeutics

Published: October 07, 2021

PALB2 variant status in hematological malignancies - a potential therapeutic target?

PALB2 variant status in hematological malignancies - a potential therapeutic target?

Journal: Leukemia & lymphoma

Published: January 08, 2019

USP7 inhibition alters homologous recombination repair and targets CLL cells independently of ATM/p53 functional status.

USP7 inhibition alters homologous recombination repair and targets CLL cells independently of ATM/p53 functional status.

Journal: Blood

Published: December 21, 2016

T-cell number and subtype influence the disease course of primary chronic lymphocytic leukaemia xenografts in alymphoid mice.

T-cell number and subtype influence the disease course of primary chronic lymphocytic leukaemia xenografts in alymphoid mice.

Journal: Disease models & mechanisms

Published: April 10, 2015

Assessment of p53 and ATM functionality in chronic lymphocytic leukemia by multiplex ligation-dependent probe amplification.

Assessment of p53 and ATM functionality in chronic lymphocytic leukemia by multiplex ligation-dependent probe amplification.

Journal: Cell death & disease

Published: January 12, 2015

Assessment of liver function in patients with hepatocellular carcinoma: a new evidence-based approach-the ALBI grade.

Assessment of liver function in patients with hepatocellular carcinoma: a new evidence-based approach-the ALBI grade.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: December 17, 2014

Targeting the Ataxia Telangiectasia Mutated-null phenotype in chronic lymphocytic leukemia with pro-oxidants.

Targeting the Ataxia Telangiectasia Mutated-null phenotype in chronic lymphocytic leukemia with pro-oxidants.

Journal: Haematologica

Published: October 20, 2014

The impact of SF3B1 mutations in CLL on the DNA-damage response.

The impact of SF3B1 mutations in CLL on the DNA-damage response.

Journal: Leukemia

Published: August 15, 2014

ATM mutation rather than BIRC3 deletion and/or mutation predicts reduced survival in 11q-deleted chronic lymphocytic leukemia: data from the UK LRF CLL4 trial.

ATM mutation rather than BIRC3 deletion and/or mutation predicts reduced survival in 11q-deleted chronic lymphocytic leukemia: data from the UK LRF CLL4 trial.

Journal: Haematologica

Published: March 04, 2014

Showing 1-12 of 14

Last Updated: 09/26/2026